Anti-VWA3A functional antibody

Anti-VWA3A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to VWA3A/VWA3A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1366-Ab-1/ GM-Tg-hg-SE1366-Ab-2Anti-Human VWA3A monoclonal antibodyHuman
GM-Tg-rg-SE1366-Ab-1/ GM-Tg-rg-SE1366-Ab-2Anti-Rat VWA3A monoclonal antibodyRat
GM-Tg-mg-SE1366-Ab-1/ GM-Tg-mg-SE1366-Ab-2Anti-Mouse VWA3A monoclonal antibodyMouse
GM-Tg-cynog-SE1366-Ab-1/ GM-Tg-cynog-SE1366-Ab-2Anti-Cynomolgus/ Rhesus macaque VWA3A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1366-Ab-1/ GM-Tg-felg-SE1366-Ab-2Anti-Feline VWA3A monoclonal antibodyFeline
GM-Tg-cang-SE1366-Ab-1/ GM-Tg-cang-SE1366-Ab-2Anti-Canine VWA3A monoclonal antibodyCanine
GM-Tg-bovg-SE1366-Ab-1/ GM-Tg-bovg-SE1366-Ab-2Anti-Bovine VWA3A monoclonal antibodyBovine
GM-Tg-equg-SE1366-Ab-1/ GM-Tg-equg-SE1366-Ab-2Anti-Equine VWA3A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1366-Ab-1/ GM-Tg-hg-SE1366-Ab-2; GM-Tg-rg-SE1366-Ab-1/ GM-Tg-rg-SE1366-Ab-2;
GM-Tg-mg-SE1366-Ab-1/ GM-Tg-mg-SE1366-Ab-2; GM-Tg-cynog-SE1366-Ab-1/ GM-Tg-cynog-SE1366-Ab-2;
GM-Tg-felg-SE1366-Ab-1/ GM-Tg-felg-SE1366-Ab-2; GM-Tg-cang-SE1366-Ab-1/ GM-Tg-cang-SE1366-Ab-2;
GM-Tg-bovg-SE1366-Ab-1/ GM-Tg-bovg-SE1366-Ab-2; GM-Tg-equg-SE1366-Ab-1/ GM-Tg-equg-SE1366-Ab-2
Products NameAnti-VWA3A monoclonal antibody
Formatmab
Target NameVWA3A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-VWA3A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1366-Ag-1Recombinant multi-species VWA3A protein


    Target information

    Target IDGM-SE1366
    Target NameVWA3A
    Gene ID146177,233813,293449,697402,119872182,101091746,522712,100058636
    Gene Symbol and SynonymsE030013G06Rik,RGD1311670,VWA3A
    Uniprot AccessionA6NCI4,A1A5Q7
    Uniprot Entry NameVWA3A_HUMAN,VWA3A_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000175267
    Target ClassificationN/A

    The target: VWA3A, gene name: VWA3A, also named as . Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.